Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those above 18 yrs vaccinated with either Covishield or Covaxin, 6 months or 26 weeks after administration of 2nd dose. @MoHFW_India approves Corbevax as #PrecautionDose for those above 18 yrs vaccinated with either Covishield or Covaxin, 6 months or 26 weeks after administration of 2nd dose. - There will be no change in existing guidelines for homologous precaution dose administration of Covaxin and Covishield, -"This enables use of Corbevax as a heterologous Covid-19 vaccine for precaution dose administration in this age group," Union Health Secretary Rajesh Bhushan said.

India Administration Covid 6 Months This Provision Dose Covishield Corbevax 26 Weeks Precaution Dose Precaution Either Covishield  check  adults  covishield  covaxin  weeks  provision  corbevax  covid  vaccinated  12  18  administration  dose  details  booster  precaution

History of this topic

The new COVID shot is now available. Here's what you need to know
4 months ago

The new COVID shot is now available. Here's what you need to know

NPR  

The new COVID shot is now available. "But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.” Sponsor Message On average across all age groups, the two mRNA vaccines should cut the risk of having COVID-19 by 60% to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
7 months, 3 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

COVID-19 in India | What is the current scenario and how are we tackling it?
8 months, 1 week ago

COVID-19 in India | What is the current scenario and how are we tackling it?

The Hindu  

Story so far: During this poll season, mentions of the COVID-19 pandemic are still doing the rounds. History of COVID-19 lockdown As COVID-19 cases – which were first reported in China’s Wuhan province – began cropping up across the world, countries employed different approaches to deal with the rise in infections, deaths and threat due to the virus, employing varying …

Covishield more effective than Covaxin: Study
9 months, 2 weeks ago

Covishield more effective than Covaxin: Study

New Indian Express  

BENGALURU: Covishield vaccine had higher antibody response compared to Covaxin during the pandemic, according to a study by a consortium of 11 institutions led by scientists from the National Centre for Biological Sciences, Bengaluru. In all, 691 people aged between 18 and 45, mostly from Bengaluru and Pune, were part of the study.’Immunogenicity of SARS - CoV-2 vaccines Covaxin and …

What study on Covishield versus Covaxin vaccine reveals
9 months, 2 weeks ago

What study on Covishield versus Covaxin vaccine reveals

The Hindu  

March 07, 2024 10:59 am | Updated March 09, 2024 10:53 am IST - Bengaluru A new study by a consortium of 11 institutes, led by scientists from the National Centre for Biological Sciences, has found that the Covishield vaccine demonstrated more robust immune responses compared to Covaxin. The key findings state that Covishield, leveraging a virus vector to deliver …

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring
9 months, 3 weeks ago

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring

India TV News  

Washington: Older US adults should roll up their sleeves for another COVID-19 shot, even if they got a booster in the fall, an influential government advisory panel said on Wednesday. The panel voted 11-1 to say Americans 65 and older should get another dose of the updated vaccine that became available in September — if at least four months have …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
11 months, 3 weeks ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
11 months, 4 weeks ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

When should I get vaccinated for COVID-19? Flu? RSV?
1 year, 3 months ago

When should I get vaccinated for COVID-19? Flu? RSV?

LA Times  

Pharmacist Aaron Sun administers a dose of the new COVID-19 vaccine to Jimmy Smagula at a CVS Pharmacy in Eagle Rock on Thursday. It’s really an updated vaccine,” said Dr. David Bronstein, pediatrician and infectious disease specialist with Kaiser Permanente Southern California, of the new COVID-19 vaccine. For people eligible and wanting to get all three vaccines this season, Bronstein …

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week
1 year, 3 months ago

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week

LA Times  

Allan Fernandez, 7, middle, is vaccinated by Dr. David Bolour, left, as CDC Director Dr. Rochelle Walensky looks on in Ted Watkins Memorial Park last year. “Although hospitalization rates are currently low in some age groups, we have seen rates increase in recent weeks, and anticipate further increases as we enter respiratory virus season.” CDC Director Dr. Mandy Cohen on …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Australian Technical Advisory Group recommends COVID-19 booster for those over 75
1 year, 3 months ago

Australian Technical Advisory Group recommends COVID-19 booster for those over 75

Daily Mail  

Minister Mark Butler urged Aussies to stay up to date on boosters ATAGI released recommendations for those over 75 to get jabbed The federal government's immunisation advisory body says the most vulnerable Australians should arrange to get yet another Covid-19 vaccination booster. The Australian Technical Advisory Group on Immunisation on Friday released fresh recommendations saying all adults over the age …

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study
1 year, 4 months ago

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study

The Hindu  

At least one dose of vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality, an Indian Council of Medical Research study on factors related to mortality within one year after discharge in hospitalised COVID-19 patients has found. Overall, the study’s findings suggest that a post-discharge mortality rate of 6.5% in patients hospitalised for COVID-19 warrants a vigilant follow-up. …

Pre-Covid shots provided 60% protection against post-infection deaths: Study
1 year, 4 months ago

Pre-Covid shots provided 60% protection against post-infection deaths: Study

India Today  

The Indian Council of Medical Research, which studied the cause of death in people after recovering from Covid-19 infection, found that those who were vaccinated before contracting the virus had 60 per cent protection against post-discharge mortality. An expert team working at the National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid, …

With coronavirus uptick, should I get a COVID shot? When are new vaccines available?
1 year, 4 months ago

With coronavirus uptick, should I get a COVID shot? When are new vaccines available?

LA Times  

The fall vaccination season is just around the corner, and officials are rolling out a new updated version of the COVID-19 vaccine. The fall vaccination season is just around the corner, and officials are set to roll out another updated version of the COVID-19 vaccine, as well as new tools to protect against RSV. Scientists say the 2023 COVID-19 vaccine …

Health council urges Covid booster for over 60s, care workers
1 year, 5 months ago

Health council urges Covid booster for over 60s, care workers

Dutch News  

The Dutch health council has said that the over 60s, pregnant women, and people with a medical condition should be offered a booster Covid shot each year. Three years after the Covid outbreak almost the entire Dutch population has built up a degree of immunity because of vaccination, infection, or both, the council said, but older people and people with …

India reports 95 new covid cases in a day
1 year, 6 months ago

India reports 95 new covid cases in a day

Live Mint  

New Delhi: India added 95 fresh coronavirus infections in the last 24 hours, while active cases fell to 1,784, according to an update by the health ministry on Wednesday.Tally of reported cases is now 4.5 crore, while death toll stands at 531,898. Covid cases have declined over the last three months after a surge in infections due to XBB.1.16 Omicron …

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases
1 year, 7 months ago

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases

Hindustan Times  

India has logged 801 new coronavirus infections, while the active cases have dipped to 14,493 from 15,515, according to the Union Health Ministry data updated on Monday. According to the ministry's website, 220.66 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive. The active cases now comprise 0.03 per cent of …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times  

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

Studies show XBB.1.16 is not clinically more severe
1 year, 8 months ago

Studies show XBB.1.16 is not clinically more severe

Hindustan Times  

The XBB.1.16 sub-variant of the Omicron strain of the SARS-CoV-2 virus that causes Covid does not exhibit higher clinical severity according to preliminary results from laboratory studies being conducted in the country to know disease characteristics, according to people familiar with the matter. According to the World Health Organisation, mutations at position 478 of the SARS-CoV-2 spike protein have been …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

‘Study on covid vaccines’ efficacy soon’
1 year, 8 months ago

‘Study on covid vaccines’ efficacy soon’

Live Mint  

New Delhi: The National Institute of Virology plans to conduct a study to determine the efficacy of vaccines with covid variants. Asked if there’s a need for a 4th dose, Yadav said in an interview, “Before we talk about 4th dose, we should enhance coverage of 3rd precautionary dose to enhance the immune response.” Only about 228.7 million Indians have …

Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

Amid Covid surge, Tricity short of vaccine doses
1 year, 8 months ago

Amid Covid surge, Tricity short of vaccine doses

Hindustan Times  

Amid a surge in Covid infections, the Tricity is facing a glaring lack of vaccine availability. Director, health services, Dr Suman Singh has confirmed that the Covid-19 vaccine is currently unavailable, and the department has already communicated this to the Government of India for additional supplies. According to data provided by the health department, a total of 10,89,773 first doses …

Active COVID-19 cases in India rise to 21,179
1 year, 8 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
1 year, 8 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times  

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

Daily COVID-19 cases in country highest in 149 days
1 year, 8 months ago

Daily COVID-19 cases in country highest in 149 days

Deccan Chronicle  

New Delhi: India logged 1,890 new coronavirus cases, the highest in 149 days, while the active cases increased to 9,433, according to the Union Health Ministry data updated on Sunday. The daily positivity was recorded at 1.56 per cent while the weekly positivity was pegged at 1.29 per cent. The Covid case tally was recorded at 4.47 crore The active …

Active COVID-19 cases in country climb to 7,026
1 year, 9 months ago

Active COVID-19 cases in country climb to 7,026

The Hindu  

India recorded 1,134 new coronavirus cases, while the active cases increased to 7,026, according to the Union Health Ministry data updated on March 22. The death toll climbed to 5,30,813 with five deaths with one each reported by Chhattisgarh, Delhi, Gujarat and Maharashtra and one reconciled by Kerala, the data updated at 8 am stated. The active cases now comprise …

India sees single-day rise of 1,071 fresh COVID cases after 129 days
1 year, 9 months ago

India sees single-day rise of 1,071 fresh COVID cases after 129 days

Deccan Chronicle  

New Delhi: India saw a single-day rise of more than 1,000 fresh COVID-19 cases after 129 days, while the active cases increased to 5,915, according to the Union health ministry data updated on Sunday. A total of 1,071 fresh cases were reported in the county in a span of 24 hours, while the death toll increased to 5,30,802 with three …

After 113 days, India sees jump in Covid cases as 524 fresh infections surface in 24 hours
1 year, 9 months ago

After 113 days, India sees jump in Covid cases as 524 fresh infections surface in 24 hours

India TV News  

Covid update: India witnessed a slight jump in fresh Covid cases on Sunday when the daily figure crossed over 500 to 524 after a gap of 113 days. The overall death, toll ever since pandemic first hit the country, has increased to 5,30,781 with one new fatality reported in Kerala, government data said. The number of people who have recuperated …

India records over 300 new Covid cases after 97 days
1 year, 9 months ago

India records over 300 new Covid cases after 97 days

Hindustan Times  

India logged more than 300 fresh coronavirus cases after 97 days, while the active cases increased to 2,686, according to the Union health ministry data updated on Saturday. The country's infection tally stands at 4.46 crore The country saw a single-day rise of 334 new cases, while the death toll rose to 5,30,775 with three latest fatalities -- two reported …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

4th COVID vaccine not needed: Expert
1 year, 10 months ago

4th COVID vaccine not needed: Expert

Live Mint  

Given the available information regarding the coronavirus and its variants, Dr. Raman Gangakhedkar, the former director of epidemiology and communicable diseases at the Indian Council of Medical Research, has questioned the need for the fourth dose of the COVID-19 vaccine. Dr. Gangakhedkar noted on the sidelines of a function on January 24 that, if a person received a third dosage …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Covid-19: Active Cases in Country Dip to 2,149
1 year, 11 months ago

Covid-19: Active Cases in Country Dip to 2,149

News 18  

India logged 104 new coronavirus infections, while the active cases declined to 2,149, according to the Union Health Ministry data updated on Sunday. The active cases comprises 0.01 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.80 per cent, according to the ministry website. According to the ministry’s website, 220.17 crore doses of Covid …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
1 year, 11 months ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

Covovax Vaccine: All you need to know about Covid-19 booster dose
1 year, 11 months ago

Covovax Vaccine: All you need to know about Covid-19 booster dose

Hindustan Times  

Covovax Vaccine: All you need to know about Covid-19 booster dose "Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield," said Chief Executive Officer Adar Poonawalla. 1 / 9 Chief Executive Officer of Serum Institute of India, Adar Poonawalla, on Sunday …

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla
1 year, 11 months ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times  

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla
1 year, 11 months ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint  

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study
1 year, 11 months ago

Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study

News 18  

Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern are higher among Covishield recipients than those who took the indigenously made Covaxin, according to a multi-centre study. Covishield elicited immune responses of higher magnitude and breadth than Covaxin in both seronegative individuals and seropositive individuals, across cohorts representing the pre-vaccination immune history of the majority of the …

Discover Related